Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2748
Abstract: Pharmacogenomic (PGx) testing has emerged as a compelling strategy that clinicians can use to inform antidepressant medication selection and dosing, but the clinical efficacy of this strategy has been questioned. We systematically reviewed and meta‐analyzed… read more here.
Keywords: clinical trials; depressive symptom; remission; symptom remission ... See more keywords
Influence of antidepressant therapy on sick leave in primary care: ADAS, a comparative observational study
Sign Up to like & getrecommendations! Published in 2019 at "Heliyon"
DOI: 10.1016/j.heliyon.2018.e01101
Abstract: Background Compared to other European countries, Sweden's yearly sick leave expenditures are moderate. Common mental disorders (CMD) are important causes of sick leave, affecting 10–15% of the adult population. A Swedish register based study indicates… read more here.
Keywords: antidepressant therapy; sick leave; longer sick; observational study ... See more keywords
Association of depression and antidepressant therapy with antiretroviral therapy adherence and health-related quality of life in men who have sex with men
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0264503
Abstract: UNAIDS’ HIV treatment targets require that 90% of people living with HIV/AIDS (PLWHA) receiving antiretroviral treatment (ART) achieve viral suppression and 90% of people with viral suppression have good health-related quality of life (HRQOL). This… read more here.
Keywords: adherence; depression; therapy; art ... See more keywords
Adherence to, and persistence of, antidepressant therapy in patients with major depressive disorder: results from a population-based study in Italy.
Sign Up to like & getrecommendations! Published in 2022 at "Current neuropharmacology"
DOI: 10.2174/1570159x20666220411092813
Abstract: BACKGROUND Major depressive disorders represent a significant burden to the society, and it is recommended that antidepressant therapy should last at least 6 months. In Italy, antidepressant use in clinical practice was reported to increase… read more here.
Keywords: therapy; major depressive; adherence persistence; antidepressant therapy ... See more keywords